Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients.

MLA

Ramos-Benitez, Marcos J., et al. “Antiviral Innate Immunity Is Diminished in the Upper Respiratory Tract of Severe COVID-19 Patients.” MedRxiv : The Preprint Server for Health Sciences, Nov. 2022. EBSCOhost, https://doi.org/10.1101/2022.11.08.22281846.

APA

Ramos-Benitez, M. J., Strich, J. R., Alehashemi, S., Stein, S., Rastegar, A., de Jesus, A. A., Bhuyan, F., Ramelli, S., Babyak, A., Perez-Valencia, L., Vannella, K. M., Grubbs, G., Khurana, S., Gross, R., Hadley, K., Liang, J., Mazur, S., Postnikova, E., Warner, S., … Chertow, D. S. (2022). Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2022.11.08.22281846

Chicago

Ramos-Benitez, Marcos J, Jeffrey R Strich, Sara Alehashemi, Sydney Stein, Andre Rastegar, Adriana Almeida de Jesus, Farzana Bhuyan, et al. 2022. “Antiviral Innate Immunity Is Diminished in the Upper Respiratory Tract of Severe COVID-19 Patients.” MedRxiv : The Preprint Server for Health Sciences, November. doi:10.1101/2022.11.08.22281846.